Current indications of lithium: Suicide risk prevention;Les indications actuelles du lithium: La prévention du risque suicidaire

Annales Medico-Psychologiques

Volumn 172, Issue 3, 2014, Pages 182-185

  Courtet, Philippe ^a   Guillaume, Sébastien ^a   Sénèque, Maude ^a   Olié, Émilie ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

Cognitive function; Lithium citrate; Prevention; Suicide risk; Therapeutic benefit

Indexed keywords

ANTICONVULSIVE AGENT; BETA CATENIN; CITALOPRAM; GLYCOGEN SYNTHASE KINASE 3; LITHIUM SALT; PHOSPHATIDYLINOSITOL 3 KINASE; PLACEBO; WNT PROTEIN;

AGGRESSION; ANTISUICIDAL ACTIVITY; ARTICLE; AUTOPSY; BIPOLAR DISORDER; BRAIN SIZE; DANISH; DECISION MAKING; DISEASE ASSOCIATION; DRUG ACTIVITY; DRUG EFFICACY; DRUG WITHDRAWAL; ETHNIC GROUP; GENETICS; HIGH RISK PATIENT; HUMAN; IMPULSIVENESS; MAJOR DEPRESSION; MICROSCOPY; MOOD DISORDER; MORTALITY; NONHUMAN; PATHOGENESIS; PRESCRIPTION; PREVALENCE; PROPHYLAXIS; RECURRENT DISEASE; RISK FACTOR; RISK REDUCTION; SIGNAL TRANSDUCTION; SUICIDE; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE;

EID: 84902082177     PISSN: 00034487     EISSN: 17696631     Source Type: Journal    
DOI: 10.1016/j.amp.2014.02.002     Document Type: Article

References (33)

1. Ahrens B., Muller-Oerlinghausen B. Does lithium exert an independent antisuicidal effect?. Pharmacopsychiatry 2001, 34:132-136.
2. American psychiatric association Diagnostic and statistical manual of mental disorders 2013, American Psychiatric Publishing, Airlington, VA. 5th ed.
3. Angst F., Stassen H.H., Clayton P.J., Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord 2002, 68:167-181.
4. Baldessarini R.J., Tondo L. Lithium and suicidal risk. Bipolar Disord 2008, 10:114-115.
5. Baldessarini R.J., Tondo L., Davis P., Pompili M., Goodwin F.K., Hennen J. Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord 2006, 8(5 Pt 2):625-639.
6. Benedetti F., Radaelli D., Poletti S., Locatelli C., Falini A., Colombo C., et al. Opposite effects of suicidality and lithium on gray matter volumes in bipolar depression. J Affect Disord 2011, 135:139-147.
7. Cipriani A., Hawton K., Stockton S., Geddes J.R. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ 2013, 346:f3646.
8. Cipriani A., Pretty H., Hawton K., Geddes J.R. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry 2005, 162:1805-1819.
9. Courtet P., Gottesman I.I., Jollant F., Gould T.D. The neuroscience of suicidal behaviors: what can we expect from endophenotype strategies?. Transl Psychiatry 2011, 1:e7.
10. Goodwin F.K., Fireman B., Simon G.E., Hunkeler E.M., Lee J., Revicki D. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA 2003, 290:1467-1473.
11. Gould T.D., Can A., Gottesman I.I., Courtet P. Differential lithium efficacy in reducing suicidal behaviors compared with suicidal thoughts. Am J Psychiatry 2012, 169:98-99. [Author reply 9].
12. Halcomb M.E., Gould T.D., Grahame N.J. Lithium, but not valproate, reduces impulsive choice in the delay-discounting task in mice. Neuropsychopharmacol 2013, 38:1937-1944.
13. Jimenez E., Arias B., Mitjans M., Goikolea J.M., Roda E., Saiz P.A., et al. Genetic variability at IMPA2, INPP1 and GSK3beta increases the risk of suicidal behavior in bipolar patients. Eur Neuropsychopharmacol 2013, 23:1452-1462.
14. Jollant F., Bellivier F., Leboyer M., Astruc B., Torres S., Verdier R., et al. Impaired decision-making in suicide attempters. Am J Psychiatry 2005, 162:304-310.
15. Jollant F., Lawrence N.S., Olie E., O'Daly O., Malafosse A., Courtet P., et al. Decreased activation of lateral orbitofrontal cortex during risky choices under uncertainty is associated with disadvantageous decision-making and suicidal behavior. Neuroimage 2010, 51:1275-1281.
16. Khan A., Khan S.R., Hobus J., Faucett J., Mehra V., Giller E.L., et al. Differential pattern of response in mood symptoms and suicide risk measures in severely ill depressed patients assigned to citalopram with placebo or citalopram combined with lithium: role of lithium levels. J Psychiatr Res 2011, 45:1489-1496.
17. Kovacsics C.E., Gottesman I.I., Gould T.D. Lithium's antisuicidal efficacy: elucidation of neurobiological targets using endophenotype strategies. Annu Rev Pharmacol Toxicol 2009, 49:175-198.
18. Lauterbach E., Felber W., Muller-Oerlinghausen B., Ahrens B., Bronisch T., Meyer T., et al. Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo-controlled, 1-year trial. Acta Psychiatr Scand 2008, 118:469-479.
19. Le-Niculescu H., Levey D.F., Ayalew M., Palmer L., Gavrin L.M., Jain N., et al. Discovery and validation of blood biomarkers for suicidality. Mol Psychiatry 2013, 18:1249-1264.
20. Llorca P.M., Courtet P., Martin P., Abbar M., Gay C., Meynard J.A., et al. Screening and management of bipolar disorders: methodology. Encephale 2010, 36(Suppl. 4):S79-S85.
21. Machado-Vieira R., Manji H.K., Zarate C.A. The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord 2009, 11(Suppl. 2):92-109.
22. Nordentoft M., Mortensen P.B., Pedersen C.B. Absolute risk of suicide after first hospital contact in mental disorder. Arch Gen Psychiatry 2011, 68:1058-1064.
23. Oquendo M.A., Galfalvy H.C., Currier D., Grunebaum M.F., Sher L., Sullivan G.M., et al. Treatment of suicide attempters with bipolar disorder: a randomized clinical trial comparing lithium and valproate in the prevention of suicidal behavior. Am J Psychiatry 2011, 168:1050-1056.
24. Pandey G.N. Biological basis of suicide and suicidal behavior. Bipolar Disord 2013, 15:524-541.
25. Richard-Devantoy S., Berlim M.T., Jollant F. A meta-analysis of neuropsychological markers of vulnerability to suicidal behavior in mood disorders. Psychol Med 2013, 1-11.
26. Rucci P., Frank E., Kostelnik B., Fagiolini A., Mallinger A.G., Swartz H.A., et al. Suicide attempts in patients with bipolar I disorder during acute and maintenance phases of intensive treatment with pharmacotherapy and adjunctive psychotherapy. Am J Psychiatry 2002, 159:1160-1164.
27. Sheard M. Effect of lithium on human aggression. Nature 1971, 230(5289):113-114.
28. Shulman K.I., Rochon P., Sykora K., Anderson G., Mamdani M., Bronskill S., et al. Changing prescription patterns for lithium and valproic acid in old age: shifting practice without evidence. BMJ 2003, 326(7396):960-961.
29. Sondergard L., Lopez A.G., Andersen P.K., Kessing L.V. Mood-stabilizing pharmacological treatment in bipolar disorders and risk of suicide. Bipolar Disord 2008, 10:87-94.
30. Squassina A., Manchia M., Chillotti C., Deiana V., Congiu D., Paribello F., et al. Differential effect of lithium on spermidine/spermine N1-acetyltransferase expression in suicidal behaviour. Int J Neuropsychopharmacol 2013, 16:2209-2218.
31. Thies-Flechtner K., Muller-Oerlinghausen B., Seibert W., Walther A., Greil W. Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Data from a randomized prospective trial. Pharmacopsychiatry 1996, 29:103-107.
32. Tondo L., Baldessarini R.J., Hennen J., Floris G., Silvetti F., Tohen M. Lithium treatment and risk of suicidal behavior in bipolar disorder patients. J Clin Psychiatry 1998, 59:405-414.
33. Wingo A.P., Wingo T.S., Harvey P.D., Baldessarini R.J. Effects of lithium on cognitive performance: a meta-analysis. J Clin Psychiatry 2009, 70:1588-1597.